Business
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities
SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings,
About this update from Goodrx Holdings, Inc.
[{"type":"text","content":" SANTA MONICA, Calif.--(BUSINESS WIRE)--\nGoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today announced its intention to refinance its first lien credit facilities.\n\n\nThe Company is seeking to refinance its first lien term loan facility and concurrently amend its revolving credit facility to extend the maturity date. The terms of the proposed refinancing, if any, will be disclosed upon the completion of the transaction, which is expected to occur during the Company’s first fiscal quarter of 2024.\n\n\nThe proposed refinancing transaction is subject to the occurrence of the effectiveness of definitive documentation for the credit facilities as well as customary closing conditions, and is subject to market and other conditions. There can be no assurance that the refinancing will occur, or, if it does, the terms of the refinancing.\n\n\nAbout GoodRx\n\n\nGoodRx is the leading destination for prescription savings. We offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. We also equip healthcare providers with efficient ways to find and prescribe affordable medications. Since 2011, GoodRx has helped consumers save more than $65 billion and is one of the most downloaded medical apps over the past decade.\n\n\nGoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission (the “SEC”) and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.\n\n\nForward-Looking Statements\n\n\nThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not rela...